Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study

27 November 2023 - Of the 2556 prescription drugs marketed by 89 companies in the study period, 256 (10.0%) had a ...

Read more →

Jazz Pharmaceuticals receives Health Canada approval for Epidiolex (cannabidiol oral solution) for the treatment of seizures associated with three rare forms of epilepsy

23 November 2023 - Jazz Pharmaceuticals Canada today announced that Epidiolex (cannabidiol oral solution), has been approved by Health Canada ...

Read more →

AnHeart Therapeutics and Innovent announce China’s NMPA has accepted a new drug application for taletrectinib (ROS1 inhibitor)

22 November 2023 - AnHeart Therapeutics and Innovent Biologics today announced that the Center for Drug Evaluation of China’s NMPA ...

Read more →

Jemperli (dostarlimab for injection) plus carboplatin and paclitaxel approved in Canada as a treatment option for primary advanced or recurrent dMMR/MSI-H endometrial cancer

16 November 2023 - Jemperli is the only immuno-oncology treatment approved for this patient population in combination with chemotherapy in Canada. ...

Read more →

Ipsen and Medison Pharma announce Health Canada approval of Bylvay (odevixibat) for the treatment of pruritus due to progressive familial intrahepatic cholestasis

13 November 2023 - Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of ...

Read more →

Informing real-time decisions with post-market drug evidence

10 November 2023 - It’s been one year since CADTH launched the Post-Market Drug Evaluation (PMDE) Program to provide decision-makers with ...

Read more →

Mitsubishi Tanabe Pharma Canada announces that Company's oral treatment formulation for amyotrophic lateral sclerosis has been added to the provincial drug plans in Prince Edward Island, Newfoundland and Labrador

7 November 2023 - Mitsubishi Tanabe Pharma Canada today announced that Radicava oral suspension (edaravone) is now covered under the Prince ...

Read more →

Health Canada approves Doptelet (avatrombopag) for two indications in thrombocytopenia

6 November 2023 - Doptelet is the only oral thrombopoietin receptor agonist without food-type restrictions or significant hepatotoxicity. ...

Read more →

Mounjaro (tirzepatide), the first and only single molecule GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes is now available in Canada

2 November 2023 - Mounjaro represents the first new class of diabetes medicines introduced in nearly a decade and is now ...

Read more →

Rhythm Pharmaceuticals receives positive CADTH reimbursement recommendation for Imcivree (setmelanotide)

2 November 2023 - Recommendation based on demonstrated clinical benefit in Phase 3 trial. ...

Read more →

Health Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder

1 November 2023 - Ultomiris transforms the treatment landscape for anti-aquaporin-4 antibody positive neuromyelitis optica spectrum disorder patients, with potential to ...

Read more →

Drugs are outrageously expensive—Canada found a way to fight back

27 October 2023 - Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the US. ...

Read more →

Organon Canada announces availability of a high concentration, citrate free formulation of Hadlima, a biosimilar to Humira

26 October 2023 - Hadlima 40 mg/0.4 mL offers a higher concentration compared to Hadlima 40 mg/0.8 mL. ...

Read more →

Health Canada authorises CSL's Hemgenix (etranacogene dezaparvovec) as first gene therapy for haemophilia B

26 October 2023 - CSL's Hemgenix is a one time, single dose treatment for adults with haemophilia B who require ...

Read more →

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) is available for the first-line treatment of adult patients with advanced or metastatic renal cell carcinoma

25 October 2023 - Merck and Eisai announced today that Keytruda, an anti-PD-1 therapy, in combination with Lenvima, the multiple receptor ...

Read more →